Journal
MOLECULAR MEDICINE REPORTS
Volume 23, Issue 2, Pages -Publisher
SPANDIDOS PUBL LTD
DOI: 10.3892/mmr.2020.11779
Keywords
sericin; MDA-MB-468; cell proliferation; PI3K; Akt signaling pathway; triple negative breast cancer
Categories
Funding
- National Natural Science Foundation of China [81441133, 81703001]
- Natural Science Foundation of Hebei Province [H2013406115]
- Chengde Medical University Scientific Research Major Projects [KY2020005]
Ask authors/readers for more resources
The study found that sericin could effectively inhibit TNBC cell proliferation, induce cell cycle arrest, and promote cellular apoptosis, primarily by downregulating the PI3K/Akt signaling pathway.
Triple negative breast cancer (TNBC) is a subtype of breast cancer characterized by an aggressive histology and poor prognosis, with limited treatment options in the clinic. In the present study, the effect of sericin, as an anti-cancer drug, on TNBC cell proliferation was investigated using a MTT assay, a colony formation assay and immunocytochemistry staining of Ki67. Results from the flow cytometry demonstrated that sericin induced G(0)/G(1) cell cycle arrest and promoted cellular apoptosis. Cell cycle and apoptosis-related proteins were detected via western blot analysis. Immunocytochemistry staining identified that P21 was translocated into the nucleus. Additionally, several pathways were significantly enriched in TNBC based on the Gene Expression Omnibus database, with the most prominent pathway being the PI3K/Akt signaling pathway. In TNBC MDA-MB-468 cells, sericin suppressed the PI3K/Akt pathway. All these findings suggested that sericin served a critical role in suppressing TNBC cell proliferation, inducing cell cycle arrest and promoting cellular apoptosis. The results indicated that the underlying molecular mechanism was, at least partially, via the downregulation of the PI3K/Akt signaling pathway.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available